arrow
Return

Advancing Cancer Interception

delete2024-04-04
delete5
delete
OA
AI
S
Susan M. Domchek *
R
Robert H. Vonderheide
DOI:10.1158/2159-8290.CD-24-0015delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Rapid advances in technology and therapeutics, along with better methods to discern who is at risk for cancer by genetic testing and other means, has enabled the development of cancer interception. Targeted therapies and immuno-interception may eliminate premalignant lesions and require clinical trial and treatment paradigms altogether distinct from current approaches.
Keywords:
PREVENTION

Journal

Cancer Discovery cover
Cancer Discovery
IF:
33.3
Papers:
3.9K
Citations:
3.7W

Organization

U
university of pennsylvania
Scholars:
9.2W
Papers: 7.8W
Citations: 153